Regeneron Announces $3 Billion Share Repurchase Program
TARRYTOWN, N.Y., Nov. 12, 2021 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that its Board of Directors authorized a share repurchase program of up to $3 billion of the Company’s outstanding common stock.
“With the strength…
